Cargando…
Narrative review of pharmacotherapy for transthyretin cardiac amyloid
Treatment of cardiac amyloidosis is determined by the amyloid type and degree of involvement. Two types of amyloid commonly infiltrate the heart: immunoglobulin light-chain amyloid (AL), and transthyretin amyloid (ATTR), that encompasses other two forms, a hereditary form (hATTR), and a sporadic, ag...
Autores principales: | Cruz Rodriguez, Jose B., Tallaj, Jose A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039703/ https://www.ncbi.nlm.nih.gov/pubmed/33850916 http://dx.doi.org/10.21037/atm-20-4636 |
Ejemplares similares
-
Narrative review: the holy grail: update on pharmacotherapy for heart failure with preserved ejection fraction
por: Paz, Pablo Alejandro, et al.
Publicado: (2021) -
Management of left ventricular thrombus: a narrative review
por: Cruz Rodriguez, Jose B., et al.
Publicado: (2021) -
Narrative review in the current role of angiotensin receptor-neprilysin inhibitors
por: Cruz Rodriguez, Jose B., et al.
Publicado: (2021) -
Editorial for “Heart Failure Update and Advances in 2021”
por: Mukherjee, Debabrata, et al.
Publicado: (2021) -
Updates in pharmacotherapy of heart failure with reduced ejection fraction
por: Espinoza, Clifton, et al.
Publicado: (2021)